Fulvestrant-Big Mac Index: Defining Inequality in Oncology

• David O'Reilly,
• Yassmeen Abu Al-Saud,
• Cian Ronayne,
• Seamus O'Reilly

Affiliations

David O'Reilly

David O'Reilly, MB BCh, and Yassmeen Abu Al-Saud, MD, Department of Medical Oncology, Cork University Hospital, Wilton, Cork, Ireland; Cian Ronayne, MPharm, MPSI, Department of Pharmacy, Cork University Hospital, Wilton, Cork, Ireland and Seamus O'Reilly, MD, PhD, Department of Medical Oncology, Cork University Hospital, Wilton, Cork, Ireland

Yassmeen Abu Al-Saud

David O'Reilly, MB BCh, and Yassmeen Abu Al-Saud, MD, Department of Medical Oncology, Cork University Hospital, Wilton, Cork, Ireland; Cian Ronayne, MPharm, MPSI, Department of Pharmacy, Cork University Hospital, Wilton, Cork, Ireland and Seamus O'Reilly, MD, PhD, Department of Medical Oncology, Cork University Hospital, Wilton, Cork, Ireland

Cian Ronayne

David O'Reilly, MB BCh, and Yassmeen Abu Al-Saud, MD, Department of Medical Oncology, Cork University Hospital, Wilton, Cork, Ireland; Cian Ronayne, MPharm, MPSI, Department of Pharmacy, Cork University Hospital, Wilton, Cork, Ireland and Seamus O'Reilly, MD, PhD, Department of Medical Oncology, Cork University Hospital, Wilton, Cork, Ireland

Seamus O'Reilly

David O'Reilly, MB BCh, and Yassmeen Abu Al-Saud, MD, Department of Medical Oncology, Cork University Hospital, Wilton, Cork, Ireland; Cian Ronayne, MPharm, MPSI, Department of Pharmacy, Cork University Hospital, Wilton, Cork, Ireland and Seamus O'Reilly, MD, PhD, Department of Medical Oncology, Cork University Hospital, Wilton, Cork, Ireland